Evidence map›Paper›PMID 15674344›Full record

ArticleOncogene2005

Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia.

K Wade Foster, Zhaoli Liu, Clinton D Nail, Xingnan Li, Thomas J Fitzgerald, Sarah K Bailey, Andra R Frost, Iuri D Louro, Tim M Townes, Andrew J Paterson and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 1 synthesis or guideline pooled it, 196 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. KATapulting toward Pluripotency and Cancer.Journal of molecular biology · 2017
    Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

K Wade FosterDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Zhaoli Liu
Clinton D Nail
Xingnan Li
Thomas J Fitzgerald
Sarah K Bailey
Andra R Frost
Iuri D Louro
Tim M Townes
Andrew J Paterson
Jeffrey E Kudlow
Susan M Lobo-Ruppert
J Michael Ruppert
University of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB Rexinoids for Breast Cancer PreventionP50CA089019 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GRIZZLE, WILLIAM E. · 2000 to 2011
$26.0M
Role of GLI in Tumor progressionR01CA094030 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RUPPERT, JOHN MICHAEL · 2002 to 2006
$1.3M
ROLE OF GKLF IN EPITHELIAL DYSPLASIAR01CA065686 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RUPPERT, JOHN MICHAEL · 2000 to 2003
$1.0M
ELA COOPERATIVE ONCOGENE PRODUCTS IN HUMAN TUMOR CELLSR29CA065686 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RUPPERT, JOHN MICHAEL · 1995 to 1999
–
NCI NIH HHS CA094030NCI NIH HHS CA65686NCI NIH HHS CA89019NCI NIH HHS P30 CA013148NCI NIH HHS P30CA13148NCI NIH HHS P50 CA089019NCI NIH HHS R01 CA065686NCI NIH HHS R01 CA094030NCI NIH HHS R29 CA065686
6 · The paper itself

Abstract

KLF4/GKLF normally functions in differentiating epithelial cells, but also acts as a transforming oncogene in vitro. To examine the role of this zinc finger protein in skin, we expressed the wild-type human allele from inducible and constitutive promoters. When induced in basal keratinocytes, KLF4 rapidly abolished the distinctive properties of basal and parabasal epithelial cells. KLF4 caused a transitory apoptotic response and the skin progressed through phases of hyperplasia and dysplasia. By 6 weeks, lesions exhibited nuclear KLF4 and other morphologic and molecular similarities to squamous cell carcinoma in situ. p53 determined the patch size sufficient to establish lesions, as induction in a mosaic pattern produced skin lesions only when p53 was deficient. Compared with p53 wild-type animals, p53 hemizygous animals had early onset of lesions and a pronounced fibrovascular response that included outgrowth of subcutaneous sarcoma. A KLF4-estrogen receptor fusion protein showed tamoxifen-dependent nuclear localization and conditional transformation in vitro. The results suggest that KLF4 can function in the nucleus to induce squamous epithelial dysplasia, and indicate roles for p53 and epithelial-mesenchymal signaling in these early neoplastic lesions.

Indexed as

AnimalsApoptosisCell DifferentiationCell DivisionCrosses, GeneticDNA-Binding ProteinsDNA PrimersDoxorubicinEpithelial CellsHumansKeratinocytesKruppel-Like Factor 4Kruppel-Like Transcription FactorsMaleMiceMice, Inbred C57BLDNA-Binding ProteinsDNA PrimersDoxorubicinKLF4 protein, humanKlf4 protein, mouseKruppel-Like Factor 4Kruppel-Like Transcription FactorsTranscription Factors

Identifiers

PMID15674344
PMCPMC1361530
OpenAlexW2164470499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.